However, radiotherapy can change the survival rate (SR) of dental implants, because it reduces the vascularity and regenerative ability of bone tissue. Hypovascularization occurs because increased bone mineral density leads to bone sclerosis, 8 whereas regenerative ability is affected because osteoblasts and osteocytes, bone-forming cells, decrease replicative capacity and bone formation, and osteoclasts, cells responsible for bone resorption, are attracted to the irradiated site. Over time, such events generate an imbalance between bone formation and resorption 9, 10 and a decrease in vascularity associated with a decrease in regenerative ability, which then affect osseointegration and the longevity of the implants. 7, 9, 10 For such reasons, radiotherapy has been considered a risk factor for this type of rehabilitation. 11 Nevertheless, implants with variable SRs have been placed in irradiated patients 12, 13 This variation can be attributed mainly to the total radiation dose received in the area. Reports 5, [14] [15] [16] [17] [18] [19] indicate values of total radiation in the range of 50 to 60 Gy are the borderline values for rehabilitation with dental implants, without the need for additional treatments such as hyperbaric oxygen therapy (HBO).
Published studies are not consistent regarding the optimal time interval between irradiation and surgery for implant placement 10 or for how different doses of radiation affect survival. 12 The purpose of this systematic review was to clarify issues regarding this theme.
The null hypothesis presented in this study was that the SR of implants placed in irradiated bone tissue does not differ from the SR of implants placed in nonirradiated tissue.
MATERIAL AND METHODS
Two independent reviewers (A.S.N., J.F.S.) conducted an electronic review of PubMed/Medline, Cochrane, and EMBASE databases for articles published in English from January 1975 to December 2013. The key words used were "radiotherapy" and "dental implants." The Boolean operators used were ("radiotherapy" [Subheading] OR "radiotherapy"[All Fields] OR "radiotherapy"[MeSH Terms]) AND ("dental implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR "dental implants"[All Fields] OR ("dental"[All Fields] AND "implant"[All Fields]) OR "dental implant"[All Fields]). A manual search was conducted in review studies addressing the subject. All titles were analyzed, selecting those relevant according to the established criteria.
The initial study selection was directed to the title and abstract analysis. Subsequently, eligible studies were analyzed and included or excluded from the total sample. Randomized controlled trials, prospective, and retrospective studies were included. Thus, the population, intervention, comparison, and outcome (PICO) criteria, as recommended by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) topic guidelines, 20 were determined as criteria for questioning to organize a clear clinical question with an appropriate inclusion focus.
The population consisted of patients who required oral rehabilitation with dental implants. The intervention was the installation of implants in irradiated patients, and the comparison was the SR of implants placed in irradiated versus those placed in nonirradiated areas. The outcome was analysis of the SRs and possible indication of implant protocols.
In order to perform the inclusion of studies, the filters selected were human studies in the English language, which contained at least 5 participants who underwent radiotherapy and received dental implants. The studies to be considered also had to report complete data of implant SRs in these regions.
Studies not included were duplicated studies, those describing the surgical technique or focusing on radiotherapy treatment, review, or clinical case studies (N5), studies published more than 20 years ago, articles that did not evaluate the SR of dental implants themselves, and nonepeer-reviewed publications. Also excluded were studies considering bone grafting as the most important factor analysis, studies in animals or extraoral implants; studies analyzing mini-implants, periimplantitis, and/or perimucositis; questionnaires about quality of life without considering the longevity of the implants; and studies of participants receiving only chemotherapy or those which focused on histological and histomorphometric analysis. The selection of the 40 studies is presented in Figure 1 .
The examiners (A.S.N., J.F.S.) selected the articles in a consensus meeting, and a third examiner (D.A.F.A.) assisted the development of this review. The articles were analyzed and discussed, and possible discrepancies were eliminated by consensus among examiners. The qualities of risk and study limitations were evaluated to eliminate studies that concealed data regarding the SR and possible complications and studies that did not define the success criteria for dental implants.
A Kaplan-Meier test was used to identify the implant survival curve in the analyzed periods and to analyze the SR of the implants installed in the irradiated maxilla or mandible. The risk ratio (RR) with a 95% confidence interval (CI) was used to study only the articles that used the installation of dental implants in the irradiated region and to compare them with those in nonirradiated regions (dichotomous outcome). In all analyses, significant values were considered when the value of P was <.05. Software (Reviewer Manager v5.3; Cochrane Group) was used for the meta-analysis and the elaboration of the forest plot and funnel plot.
The random effects model was used in the comparative analysis of implants placed in irradiated and nonirradiated regions. Heterogeneity was considered significant for P<.1 and analyzed using the Q(x 2 ) method, and the I 2 value was measured. Data were presented qualitatively, allowing
Clinical Implications
Many clinicians consider head and neck radiotherapy to be a risk factor for dental implant placement. However, as many irradiated patients are rehabilitated with implant-supported prostheses, the evaluation of clinical risk is important.
comparison of the studies analyzed (N=40) and quantitatively in order to study the survival of the implants.
RESULTS
According to the inclusion and exclusion criteria established, 40 articles were selected: 1 randomized, 18 prospective, and 21 retrospective. The total number of participants was 2220, with an average 58 years of age.
Regarding implant locations, 13 studies identified the number of installed implants in the maxilla and mandible. 1, [3] [4] [5] 13, 15, 18, 19, [21] [22] [23] [24] [25] A greater number of implants had been installed in the mandible (2185) than in the maxilla (796). The average SR of implants placed in the mandible was higher than the SR of implants placed in the maxilla (Fig. 2) .
Irradiated patients received doses ranging from 10 to 145 Gy, and the interval between radiotherapy and implant installation surgery ranged from 1 to 240 months, with an average minimum timeout of 11.82 months. There were also participants for whom radiotherapy was performed after implant installation. 5, 12, 24 A total of 9231 implants were installed in irradiated and nonirradiated participants with variable geometry; the lowest reported diameter was 3.3 mm, and the minimum length was 7.0 mm. The follow-up period from implant placement until the last control of the implant in function ranged from 1 to 276 months.
Of 5562 implants placed in irradiated participants, 862 (15.49%) were classified as failures, whereas 3669 implants were installed in nonirradiated participants with 191 (5.20%) failures. The brand name most used was Nobel Biocare (Table 1) .
In quantitative analysis, a total of 5489 implants were placed in irradiated bone tissue regions, and a total of 862 failures were found in a follow-up period of up to 192 months. The Kaplan-Meier analysis indicated an 84.33% SR during the period from 0 to 192 months (Fig. 3) . Moreover, as presented in Table 2 , the failures occurred in all analyzed periods, but the highest SR reductions occurred after 60 months. The overall results of this review reveal that the percentage of failures tended to increase in patients undergoing radiotherapy, decreasing the SR of these implants.
In a specific analysis of the number of implants that failed during follow-up, statistically significant differences between irradiated and nonirradiated regions that received dental implants were reported in 26 studies. The sum of implant failures revealed 860 implant failures in the irradiated group and 186 implant failures in the nonirradiated group.
In analysis based on random effects, statistically significant differences were observed in the failure of implants placed in irradiated bone tissue (RR: 2.63; 95% CI: 1.93-3.58; P<.001) (Fig. 4) .
The heterogeneity observed in studies of implant failure outcome was relevant (chi-square: 56.46; P<.0003; I 2 : 56%), using the random effects model. The funnel chart indicated a clear symmetry between the differences of the relative risks of the studies analyzed, reducing rates of bias of the study (Fig. 5) .
DISCUSSION
This systematic review revealed that the concept of controlled and randomized clinical trials was used only by Schoen et al. 39 High financial costs and detailed planning are involved in controlled and randomized clinical trials that use significant numbers of participants undergoing radiotherapy. For this reason, the sample of included studies basically consisted of retrospective and prospective trials (Table 3) , which can be considered biased in this review. Twelve studies analyzed the SR of implants regarding location. 1, 5, 12, 13, 15, 16, 18, 19, 22, [24] [25] [26] In most of the studies, the SR of implants in the mandible was higher than those in the maxilla (Fig. 2) . However, Andersson et al, 5 Granstrom et al, 12 and Mericske-Stern et al 24 found higher SRs in the maxilla. The differences between these results is primarily due to bone quality and vascularization capacity. 12 The mandible presents a more cortical bone, and therefore, obtaining primary stability is easier. However, the greater SR observed in 3 studies in the maxilla can be explained because the maxilla has a more trabecular bone, and hence, greater vascularization, thus favoring the secondary stability of implants. 44 Four studies did not identify significant differences. 3, 4, 21, 23 Although they did not provide data about the SR, they did analyze the statistical correlation (a=.05) between maxillary and mandibular rates. None showed statistically significant differences for the mandible and maxilla SRs.
The results showed a wide variation in total dosage of radiation received, from 10 to 145 Gy (Table 1) , and these values changed according to the purpose of the treatment, location, and diagnosis of the lesion. 17 The treatment consisted of radiotherapy dosages applied in daily fractions of up to 2 Gy, carried out 3 to 5 times per week. 3, 16, 23, 25 Even though no article included in this review approached intensity-modulated radiation therapy (IMRT), it is important to highlight this modality, which is a high-precision radiotherapy. IMRT allows high doses of radiation to be applied to the target but with minimum involvement of adjacent tissues. Because this radiotherapy modality damages healthy tissues less, it is mainly indicated for treatment next to structures and/or vital organs, such as in patients with head and neck tumors. 46, 47 Some studies reached consensus 5, 14, 16, 18 on the risk of the radiotherapy dose, values of 50 to 60 Gy were predominant. In those situations, the use of HBO would be indicated, because this treatment improves bone repair and assists in the osseointegration process 24 by stimulating the irradiated tissues and significantly increasing the oxygen content areas prone to osteoradionecrosis. In the included studies, some authors did not use HBO, explaining that the total radiotherapy dose applied was low. 26 In other studies, 3,29 even with irradiation rates above that range, HBO was not applied as there was no consensus on the need for this treatment.
Some studies 7, 12, 13, 19, 24, 37, 39, 45 used HBO as adjuvant treatment to radiotherapy. Although increases in the SR of irradiated implants could not be verified by some authors, 13, 19, 39 significant biases were found in these studies. Niimi et al 13 claimed that the follow-up period was not enough to assert that HBO was not required because microvascular circulation decreases over time, whereas the effect of HBO continues for many years. In the studies of Shaw et al 19 and Schoen et al, 39 relevant information that could also influence the SR of the implants, such as diameter, length, and surface treatment, was not correlated.
In contrast, other studies 7,12,45 observed significant improvements in regard to the SRs of implants in the irradiated areas subjected to HBO or as an indication of treatment for osteoradionecrosis. 24 The results presented by Granstrom et al 45 deserve attention. In that study, 4 groups of patients were evaluated, with 1 group consisting of irradiated patients who had lost 34 of 43 implants. After losing implants, such patients underwent treatment with HBO, after which 42 new implants were installed; only 5 were considered failures. Therefore, the success rate rose from 21% to 88.1%, confirming the effectiveness of HBO for this group.
In order to analyze the effectiveness of HBO and answer the possible questions regarding this treatment, a search of high scientific evidence studies, specifically for irradiated patients treated with HBO, was performed. The meta-analysis of Bennett et al 48 stated that HBO mitigated the effects caused by radiotherapy in the head and neck. However, because of the inclusion of a single study with dental implants, the study did not conclude anything specific on this topic. In contrast, the systematic review of Chambrone et al 49 addressed implants and stated that HBO did not improve the SR of the implants; in this report, HBO was not the focus of the review, and only 3 studies addressing the issue in question were included. The authors stated that insufficient data were available to support or reject the use of HBO. It appears that there is still no consensus regarding the treatment of irradiated patients also treated with HBO who are rehabilitated with implants. More randomized clinical trials using this treatment to clarify this important issue are suggested.
Another important factor is the waiting period between the last session of radiotherapy and implant surgery. In the present study, this factor varied greatly from 1 to 240 months. However, Table 1 shows that the minimum time adopted by most authors 2,3,18,23,25 was 6 months. Sammartino et al 18 compared 2 groups of participants: the first had implants installed within a waiting period of less than 12 months, and the second group had implants installed after 12 months. The study found that short waiting periods, less than 12 months, do not guarantee a suitable quality of bone and vascularization, which are factors directly related to osseointegration of the implants. Therefore, the largest number of faults found in the group with placement of implants after radiotherapy is explained. The study of Brasseur et al, 50 when evaluating the installation of implants in beagle dogs before and after radiotherapy, found a better osseointegration, very similar to that in the control, in the group that had implants installed first and then underwent radiation doses. The authors attribute the fact that osseointegration in the previously irradiated implant placement group was not similar to that of the control group to the short time between the end of radiotherapy sessions and implant surgery. However, waiting for osseointegration to install implants and only then applying radiotherapy may be contraindicated, because tumor malignancy and the risk of metastasis requires prompt treatment.
Regarding the geometry of the implant, Goto et al 26 observed a greater number of failures in short implants, recommending caution in the use of these implants in irradiated patients. Nevertheless, in the comparative study of Niimi et al, 13 one group exhibited a higher number of failures in implants of 7 to 10 mm in length, whereas in the second group, most failures occurred in implants of 13 to 15 mm in length, suggesting that implant failure can occur regardless of length. However, since this article was published, surface treatments have been developed, 1 and the results may be different. Nevertheless, a current systematic review 51 highlights the view that shorter implants present a greater risk of failure than standard implants, and clinicians must be aware of mechanical and biological care. In this review, a consensus on this issue could not be reached because most of the included studies did not address this information. Future clinical trials should address and analyze such data, as well as the type of implant surface treatment.
Regarding the surface treatment of implants, Buddula et al 1 analyzed a single brand of implants. However, Survival Rate (%) Figure 3 . Survival curve analysis of implants installed in irradiated bone tissue. Survival curve of 84.33% in 192 months. [1] [2] [3] [4] [5] [6] [7] [11] [12] [13] [14] [15] [16] [17] 19, one group used machined implants and another used surface treatment implants. They verified that the machined implants tended to fail 2.9 times more than the implants with surface treatment. The properties of the implant surfaces, such as topography and chemical treatment, 23 are important factors. In addition to providing greater contact between the bone and the implant, especially in areas of less corticalized bone tissue, which favors biological responses that accelerate the osseointegration process, surface treatments also increase mechanical strength and reduce corrosion. 52, 53 The diversity of brands of implants tested is shown in Table 1 . However, few studies 7, 12, 19, 21, 23, 25, 36 specified the brand of implants placed, and the authors did not correlate the implant SR when different types were used in the same study, the only exceptions being Buddula et al, 1 Landes and Kovacs, 27 and Studies grouped according to resemblances in their methodology.
Nelson et al. 25 Some of the studies 3, 14, 17, 18, 26, 31, 37, 40, 43 did not even identify the brand of implants.
The main outcome of the presnt study was that the success rate of implants placed in irradiated tissue was lower than that of implants placed in nonirradiated tissue (P<.001); thus, the null hypothesis was rejected. Homogeneity was noted in the included studies, which showed a lower SR in irradiated sites (Fig. 4) . The only exception was the retrospective study of Al-Nawas et al, 21 where results showed that the risk of implant loss in nonirradiated patients was higher than in irradiated patients. The authors 21 attributes such results to the use of bone grafts and also to the bias of the study, which presented a small number of participants undergoing radiotherapy compared with the total number of participants.
The lowest SR in irradiated sites is explained in the study of Verdonck et al, 44 where, although the primary stability of implants in irradiated and nonirradiated sites was very similar, the secondary stability of implants in irradiated areas was damaged over time. This difference is because the primary stability depends only on the bone density where the implant was installed, whereas secondary stability, which is related to osseointegration effectiveness, depends on bone remodeling that is directly linked to vascularization. Some studies, 2,4,5,7,9,10,21 despite having cited some complications like periimplantitis and osteonecrosis, did not give due relevance to the question, the exception being Granstrom et al. 45 Complications in such patients can have serious consequences, for which, at times, no possible treatment is available.
Finally, this study supports the predictability of dental implants in irradiated patients, because it can improve the quality of life for patients and can facilitate social rehabilitation. A strict treatment protocol with detailed periodic monitoring by the dentist, including occlusal adjustments, contact points, radiographic follow-up, and cleaning techniques, should be performed. However, to establish a protocol of treatment, the waiting interval, the dose risk, and the most appropriate geometries of implants for irradiated patients, new studies must be conducted as randomized and double-blind trials.
CONCLUSIONS
Although the results of this meta-analysis state that the favorable SR of implants installed in irradiated areas is 85% after 16 years of follow-up, only a few studies performed a lengthy follow-up, which may be a bias of this result. This study concluded that dental implants placed in irradiated areas have a lower SR than those installed in nonirradiated areas, and possible complications are a high-risk threat throughout the life of these patients. Close monitoring is necessary to avoid complications and reduce the chances of failure.
